From: Economic evaluation of pharmacogenomic-guided antiplatelet treatment in Spanish patients suffering from acute coronary syndrome participating in the U-PGx PREPARE study
Complete at nurse assessment on
Date of assessment (n = 243)
Utility values (n = 243)
Baseline Visit
243 (100%)
Week 4
241 (99.1%)
239 (98.3%)
Week 12
238 (97.9%)
234 (96.2%)
18Â months
163 (67%)
160 (65.8%)